Nanoparticles: New agents toward treatment of leishmaniasis
Leishmaniasis is a widespread disease that causes 20,000 to 30,000 deaths annually, making it a major health problem in endemic areas. Because of low-performance medications, drug delivery poses a great challenge for better treatment of leishmaniasis. The present study's purpose was to review t...
Main Authors: | Amir Nafari, Koroush Cheraghipour, Maryam Sepahvand, Ghazal Shahrokhi, Esraa Gabal, Hossein Mahmoudvand |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-08-01
|
Series: | Parasite Epidemiology and Control |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405673120300258 |
Similar Items
-
Application of Liposome Technology in the Treatment of Leishmaniasis: Past, Present and Future
by: Amir Mellati, et al.
Published: (2023-12-01) -
THE STUDY OF LEISHMANIASIS USING THE METHOD OF POLYMERASE CHAIN REACTION
by: E. N. Zhirenkina
Published: (2022-12-01) -
Disseminated Leishmaniasis, a Severe Form of Leishmania Braziliensis Infection
by: Paulo R.L. Machado, et al.
Published: (2024-03-01) -
Visceral Leishmaniasis, Northern Somalia, 2013–2019
by: Mikko K. Aalto, et al.
Published: (2020-01-01) -
Cutaneous Leishmaniasis Caused by an Unknown Leishmania Strain, Arizona, USA
by: Marcos de Almeida, et al.
Published: (2021-06-01)